NeuroLambda Therapeutics
NeuroLambda Therapeutics is a startup headquartered in Cambridge, United States, founded in 2023. It has raised at least $3.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
NeuroLambda Therapeutics has raised at least $3.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
NeuroLambda Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does NeuroLambda Therapeutics do?
NeuroLambda Therapeutics is classed in technology in its filings with the US Securities and Exchange Commission.
How much has NeuroLambda Therapeutics raised?
At least $3.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is NeuroLambda Therapeutics based?
NeuroLambda Therapeutics is headquartered in Cambridge, United States.
When was NeuroLambda Therapeutics founded?
NeuroLambda Therapeutics was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.